LOGO
LOGO

Email This Article

Hikma Pharma FY25 Earnings Rise; Launches $250 Mln Buyback, Guides FY26; Shares Plunge
To Email: *
Bcc: Seperate multiple addresses with commas(,)
Your Email: *
Format :

* Denotes Required Fields